Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations

Tamiya, Motohiro; Tamiya, Akihiro; Shiroyama, Takayuki; Takeoka, Sawa; Naito, Yujiro; Omachi, Naoki; Kimura, Yohei; Morishita, Naoko; Suzuki, Hidekazu; Okamoto, Norio; Okishio, Kyoichi; Kawaguchi, Tomoya; Atagi, Shinji; Hirashima, Tomonori

期刊名称Investigational New Drugs
作者Tamiya, Motohiro; Tamiya, Akihiro; Shiroyama, Takayuki; Takeoka, Sawa; Naito, Yujiro; Omachi, Naoki; Kimura, Yohei; Morishita, Naoko; Suzuki, Hidekazu; Okamoto, Norio; Okishio, Kyoichi; Kawaguchi, Tomoya; Atagi, Shinji; Hirashima, Tomonori
印刷ISSN0167-6997
电子ISSN1573-0646
文件大小508.56KB
发表时间2017-11-4
DOI10.1007/s10637-017-0527-z

发现好书期刊，享受阅读乐趣

Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations